DJIA 17,122.01 0.00 0.00%
NASDAQ 4,569.62 0.00 0.00%
S&P 500 2,000.12 0.00 0.00%
market minute promo

Novartis (NYSE: NVS)

90.00 0.00 (0.00%)

REAL-TIME: Last trade at

Extended Hours: $89.44 -$0.56 (-0.62%)
Quote as of (NYSE)



company name or ticker

Recent Quotes

NVS $90.00 0.00%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $90.25
Previous Close $90.00
Daily Range $89.80 - $90.28
52-Week Range $72.24 - $91.66
Market Cap $218.4B
P/E Ratio 24.25
Dividend (Yield) $2.72 (2.6%)
Ex-Dividend Date
Dividend Pay Date
02/27/14
04/10/14
Volume 1,118,076
Average Daily Volume 1,018,072
Current FY EPS $5.19

Sector

Healthcare

Industry

Drugs

Novartis (NVS) Description

Operates in the business of patent-protected and generic pharmaceuticals as well as consumer health products. Website: http://www.novartis.com/

News & Commentary

3 Reasons Pfizer Inc.'s Stock Could Fall

Despite rumors about mergers and acquisitions, these three catalysts could wind up pressuring Pfizer's stock and ultimately pushing it lower.

Alkermes Gains on Aripiprazole Lauroxil NDA Submission - Analyst Blog

Heating up: Burger King is latest in M&A frenzy

Apricus Biosciences: A Screaming Buy Or A Falling Knife?

Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for August 22, 2014

Pre-Market Activity Shows Heavy Volume And Movement For Novartis (NVS)

Pre-Market Most Active for Aug 21, 2014 : NVS, BAC, MCC, HTZ, DG, JRJC, NOK, AAPL, QQQ, DLTR, FB, T

Pre-Market Most Active for Aug 21, 2014 : NVS, BAC, MCC, HTZ, DG, JRJC, NOK, AAPL, QQQ, DLTR, FB, TVIX

Novartis to Invest $35M in Gamida Cell for 15% Equity - Analyst Blog

Novartis to Invest $35M in Gamida Cell for 15% Equity - Analyst Blog

Apricus Biosciences' ED Treatment Vitaros Now in Germany - Analyst Blog

Pfizer Submits Palbociclib Marketing Application to the FDA - Analyst Blog

See More NVS News...

NVS's Top Competitors

NVS $90.00 (0.00%)
Current stock: NVS
JNJ $103.22 (0.00%)
Current stock: JNJ
MRK $60.28 (0.00%)
Current stock: MRK
GSK $48.67 (0.00%)
Current stock: GSK